Abstract A239: Preclinical Characterization of ABT-348, a Kinase Inhibitor Targeting the Aurora, VEGFR/PDGFR, and SRC Kinase Families.
Keith B. Glaser,Junling Li,Patrick A. Marcotte,Terrance J. Magoc,Jun Guo,David R. Reuter,Paul Tapang,Ru-Qi Wei,Lori J. Pease,Mai H. Bui,Zehan Chen,Robin R. Frey,Eric F. Johnson,Donald J. Osterling,Amanda M. Olson,Jennifer J. Bouska,Michael L. Curtin,Cherrie K. Donawho,Michael R. Michaelides,Chris Tse,Steven K. Davidsen,Daniel H. Albert Molecular Cancer Therapeutics（2011）
AI 理解论文
溯源树
样例
